GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (STU:XE7C) » Definitions » FCF Yield %

Cardiff Oncology (STU:XE7C) FCF Yield % : -15.79 (As of Apr. 30, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cardiff Oncology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cardiff Oncology's Trailing 12-Month Free Cash Flow is €-29.21 Mil, and Market Cap is €186.12 Mil. Therefore, Cardiff Oncology's FCF Yield % for today is -15.79%.

The historical rank and industry rank for Cardiff Oncology's FCF Yield % or its related term are showing as below:

STU:XE7C' s FCF Yield % Range Over the Past 10 Years
Min: -491.81   Med: -25.89   Max: -2.42
Current: -15.79


During the past 13 years, the highest FCF Yield % of Cardiff Oncology was -2.42%. The lowest was -491.81%. And the median was -25.89%.

STU:XE7C's FCF Yield % is ranked worse than
51.06% of 1551 companies
in the Biotechnology industry
Industry Median: -15.06 vs STU:XE7C: -15.79

Cardiff Oncology's FCF Margin % for the quarter that ended in Dec. 2023 was -4,582.52%.


Cardiff Oncology FCF Yield % Historical Data

The historical data trend for Cardiff Oncology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology FCF Yield % Chart

Cardiff Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -126.97 -2.64 -9.52 -59.08 -50.62

Cardiff Oncology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.23 -48.40 -46.51 -55.96 -45.98

Competitive Comparison of Cardiff Oncology's FCF Yield %

For the Biotechnology subindustry, Cardiff Oncology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiff Oncology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardiff Oncology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cardiff Oncology's FCF Yield % falls into.



Cardiff Oncology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cardiff Oncology's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-28.857 / 57.007852
=-50.62%

Cardiff Oncology's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.553 * 4 / 57.007852
=-45.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardiff Oncology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Cardiff Oncology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiff Oncology (STU:XE7C) Business Description

Traded in Other Exchanges
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Cardiff Oncology (STU:XE7C) Headlines

No Headlines